DataBiologics

DataBiologics

Harnessing real patient feedback to benchmark providers and products in cash-pay medicine

Print
Follow Claim My Business
Security Type
CAFES
Categories
Technology, Healthcare & Medical, Fast Growth, Other, VC-Backed
Min Investment
$100
Location
Mesa, , AZ
No. Investors
61

Key Deal Facts

Rapidly growing market, 6X revenue growth Aug 2023-24 and over $500k in ARR.
Large national database of 130+ clinics, 220+ providers, 20k+ patients tracked.
Easy data entry, pre-loaded outcomes assessments, automated patient messaging, data visualization.
Glowing customer reviews and testimonials.
Clients include Emory Healthcare, OhioHealth, SoftWave, and QC Kinetix
Over 90% retention of paying customers.
Backed by two Venture accelerator/studios.
Founded by physicians, for physicians.

Management Team / Advisory Board Bios

Fast Growth
Revenue growing 2X/yr for at least prior 6 months, Leah Braddell CEO & CTO20+ years broad industry experience, accomplished biomedical R&D engineer turned award winning sales/marketing leader at Intuitive Surgical, deep tech investor, highly experienced real-world health data scientist, technical, and commercial recruiter., Luke Malanga COO & CPODeep domain knowledge and influential physician networker. Lifelong experience with regenerative medicine physicians and treatment market., Christopher Rogers Chief Medical OfficerFounder, San Diego Orthobiologics Medical Group; Medical Director, Personalized Stem Cells, Inc, Jay BowenChief Science OfficerPresident, American Medical Shockwave Society; Medical Director, New Jersey Regenerative Institute, LLC
Amount Raised : $259,138
Reveal the Score by Voting
_
0
Business Idea
Business Traction
Management Team
Valuation

Security Description

A CAFES (Contract and Future Equity Stake) can convert into different types of equity upon a Triggering Event, such as: common or preferred stock for a corporation, limited partnership interest for a limited partnership and membership interest for a limited liability company. At the time of the Triggering Event, the specific rights and limitations associated with the equity stake being issued to the investors will be determined and disclosed by the Entrepreneur.

Research Reports

No reports have been submitted

Become a Reporter

0 Comments